These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38001904)

  • 21. Advanced basal cell carcinoma: What dermatologists need to know about treatment.
    Wilson M; Johnson RP; Senft SC; Pan EY; Krakowski AC
    J Am Acad Dermatol; 2022 Jun; 86(6S):S14-S24. PubMed ID: 35577406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical management of giant skin tumor - A case report.
    Usheva S; Vassilev I; Jelev G; Sedloev T; Dimitrov I; Terziev I; Boyadzhieva M; Milusheva Y; Troyanova P
    Ann Chir Plast Esthet; 2024 Mar; 69(2):154-159. PubMed ID: 37423823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basosquamous carcinoma: appearance and reality.
    Anand RL; Collins D; Chapman A
    Oxf Med Case Reports; 2017 Jan; 2017(1):omw095. PubMed ID: 28058108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of dermoscopy in the diagnosis of basosquamous carcinoma].
    Elmahi H; Lahlou A; Baybay H; Gallouj S; Mernissi FZ; Reggad FZ; Harmouch T
    Pan Afr Med J; 2016; 25():252. PubMed ID: 28293368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma.
    Dummer R; Guminski A; Gutzmer R; Dirix L; Lewis KD; Combemale P; Herd RM; Kaatz M; Loquai C; Stratigos AJ; Schulze HJ; Plummer R; Gogov S; Pallaud C; Yi T; Mone M; Chang AL; Cornélis F; Kudchadkar R; Trefzer U; Lear JT; Sellami D; Migden MR
    J Am Acad Dermatol; 2016 Jul; 75(1):113-125.e5. PubMed ID: 27067394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection by (18)F-FDG PET of unsuspected extensive bone marrow metastases in a case of basosquamous carcinoma of the cheek.
    Joshi P; Kulkarni MJ; Abhyankar A; Shet T; Basu S
    Hell J Nucl Med; 2011; 14(3):307-8. PubMed ID: 22087455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reappraising basosquamous carcinoma: a summary of histologic features, diagnosis, and treatment.
    Shukla S; Khachemoune A
    Arch Dermatol Res; 2020 Nov; 312(9):605-609. PubMed ID: 32166375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and pharmacodynamics of Hedgehog pathway inhibitors used in the treatment of advanced or treatment-refractory basal cell carcinoma.
    Lear JT; Morris LM; Ness DB; Lewis LD
    Expert Rev Clin Pharmacol; 2023; 16(12):1211-1220. PubMed ID: 37975712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sonidegib for the Treatment of Advanced Basal Cell Carcinoma.
    Brancaccio G; Pea F; Moscarella E; Argenziano G
    Front Oncol; 2020; 10():582866. PubMed ID: 33194718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical clearance of complex basal cell carcinoma in patients receiving sonidegib: A case series.
    Leow LJ; Teh N
    Dermatol Ther; 2022 Feb; 35(2):e15217. PubMed ID: 34816547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Line-field confocal optical coherence tomography of basosquamous carcinoma: a case series with histopathological correlation.
    Cappilli S; Cinotti E; Lenoir C; Tognetti L; Perez-Anker J; Rubegni P; Puig S; Malvehy J; Perrot JL; Del Marmol V; Peris K; Suppa M
    J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):1214-1218. PubMed ID: 35224784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma.
    Doan HQ; Silapunt S; Migden MR
    Onco Targets Ther; 2016; 9():5671-5678. PubMed ID: 27695345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic Targeted Treatments for Basal Cell Carcinoma.
    Svoboda SA; Johnson NM; Phillips MA
    Cutis; 2022 Jun; 109(6):E25-E31. PubMed ID: 35960978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dermoscopy of basosquamous carcinoma.
    Giacomel J; Lallas A; Argenziano G; Reggiani C; Piana S; Apalla Z; Ferrara G; Moscarella E; Longo C; Zalaudek I
    Br J Dermatol; 2013 Aug; 169(2):358-64. PubMed ID: 23607676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using drug scheduling to manage adverse events associated with hedgehog pathway inhibitors for basal cell carcinoma.
    Lear JT; Dummer R; Guminski A
    Oncotarget; 2021 Dec; 12(26):2531-2540. PubMed ID: 34966484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basosquamous carcinoma and metatypical basal cell carcinoma: a review of treatment with Mohs micrographic surgery.
    Allen KJ; Cappel MA; Killian JM; Brewer JD
    Int J Dermatol; 2014 Nov; 53(11):1395-403. PubMed ID: 24961583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Locally advanced basal cell carcinoma: Real-life data with sonidegib.
    Toffoli L; Conforti C; Zelin E; Vezzoni R; Agozzino M; di Meo N; Zalaudek I
    Dermatol Ther; 2022 Jun; 35(6):e15441. PubMed ID: 35279921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of basal cell carcinoma with pulmonary metastasis.
    Fordham SA; Shao EX; Banney L; Azer M; Dettrick A
    BMJ Case Rep; 2023 Jan; 16(1):. PubMed ID: 36599494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Known and new facts on basal cell carcinoma.
    Seidl-Philipp M; Frischhut N; Höllweger N; Schmuth M; Nguyen VA
    J Dtsch Dermatol Ges; 2021 Jul; 19(7):1021-1041. PubMed ID: 34288482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-Like Receptor 7 Staining in Malignant Epithelial Tumors.
    Franz R; Ritter N; Hein R; Biedermann T; Al-Sisi M; Eyerich K; Garzorz-Stark N; Andres C
    Am J Dermatopathol; 2017 Oct; 39(10):742-746. PubMed ID: 28857981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.